Novel Mechanistic Study of HDAC6 Regulation of Rheumatoid Arthritis Via CMA: Exploring Potential Therapeutic Targets

Overview

Journal Front Pharmacol

Date 2024 Apr 5

PMID 38576491

Authors

Duoduo Lin

Weipeng Lai

NingNing Zheng

Hongbin Luo

Xiaole Chen

Wenzhong Que

Nanwen Zhang

Affiliations

Soon will be listed here.

Abstract

Objective: Rheumatoid arthritis (RA) is a systemic autoimmune disease. Its pathogenesis has not yet been clarified, so it is urgent to explore therapeutic targets. Here, we clarified the role of HDAC6 in the mechanism of action of RA through mediating chaperone-mediated autophagy (CMA) to provide a clinical treatment of RA.

Methods: We used rheumatoid arthritis fibroblast-like synoviocytes (RA-FLS) and collagen-induced arthritis mice (CIA mice) as models of RA and pharmacological inhibitors as well as genetic interference with adeno-associated viruses to reduce the expression of HDAC6. We explored the influence of CAY10603 on RA-FLS proliferation and inflammation, as well as the expression of proteins related to the CMA signaling pathway. CIA model was constructed using DBA/1J mice. Arthritis symptoms in CIA mice were evaluated, and the expression and localization of CMA-related proteins in mouse ankle joints were examined.

Results: CAY10603 inhibited proliferation as well as the level of the molecular chaperone autophagy in RA-FLS. HDAC6 shRNA significantly reduced the clinical signs of arthritis in CIA mice, as did the expression of HDAC6 in the serum and ankle synovial tissues of CIA mice. Finally, it significantly inhibited the level of Hsc70 and LAMP-2A, which are involved in the CMA signaling pathway, in ankle joint tissues.

Conclusion: Downregulation of HDAC6 may inhibit CMA and thereby ameliorate RA.

References

Li Z, Duan P, Qiu R, Fang L, Fang P, Xiao S . HDAC6 Degrades nsp8 of Porcine Deltacoronavirus through Deacetylation and Ubiquitination to Inhibit Viral Replication. J Virol. 2023; 97(5):e0037523. PMC: 10231189. DOI: 10.1128/jvi.00375-23. View

Nass S, Steele F, Ware T, Libby A, Hsu K, Kinsey S . Monoacylglycerol Lipase Inhibition Using JZL184 Attenuates Paw Inflammation and Functional Deficits in a Mouse Model of Inflammatory Arthritis. Cannabis Cannabinoid Res. 2021; 6(3):233-241. PMC: 8217598. DOI: 10.1089/can.2020.0177. View

Choudhary N, Bhatt L, Prabhavalkar K . Experimental animal models for rheumatoid arthritis. Immunopharmacol Immunotoxicol. 2018; 40(3):193-200. DOI: 10.1080/08923973.2018.1434793. View

Kaur S, Rajoria P, Chopra M . HDAC6: A unique HDAC family member as a cancer target. Cell Oncol (Dordr). 2022; 45(5):779-829. DOI: 10.1007/s13402-022-00704-6. View

Fraenkel L, Bathon J, England B, St Clair E, Arayssi T, Carandang K . 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2021; 73(7):924-939. PMC: 9273041. DOI: 10.1002/acr.24596. View

AlMutairi K, Nossent J, Preen D, Keen H, Inderjeeth C . The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review. Rheumatol Int. 2020; 41(5):863-877. DOI: 10.1007/s00296-020-04731-0. View

Qiao L, Ma J, Zhang Z, Sui W, Zhai C, Xu D . Deficient Chaperone-Mediated Autophagy Promotes Inflammation and Atherosclerosis. Circ Res. 2021; 129(12):1141-1157. PMC: 8638823. DOI: 10.1161/CIRCRESAHA.121.318908. View

Leo D, Green G, Eastwood D, Bridgens A, Gelfer Y . Development of a core outcome set for the orthopaedic management of spinal dysraphism : a study protocol. Bone Jt Open. 2022; 3(1):54-60. PMC: 9047074. DOI: 10.1302/2633-1462.31.BJO-2021-0157.R1. View

Jo H, Shim K, Jeoung D . Targeting HDAC6 to Overcome Autophagy-Promoted Anti-Cancer Drug Resistance. Int J Mol Sci. 2022; 23(17). PMC: 9455701. DOI: 10.3390/ijms23179592. View

10.

Li Z, Chen M, Wang Z, Fan Q, Lin Z, Tao X . Berberine inhibits RA-FLS cell proliferation and adhesion by regulating RAS/MAPK/FOXO/HIF-1 signal pathway in the treatment of rheumatoid arthritis. Bone Joint Res. 2023; 12(2):91-102. PMC: 9950669. DOI: 10.1302/2046-3758.122.BJR-2022-0269.R1. View

11.

Ma C, Wang J, Hong F, Yang S . Mitochondrial Dysfunction in Rheumatoid Arthritis. Biomolecules. 2022; 12(9). PMC: 9496243. DOI: 10.3390/biom12091216. View

12.

Bae D, Choi Y, Lee J, Ha N, Suh D, Baek J . M-134, a novel HDAC6-selective inhibitor, markedly improved arthritic severity in a rodent model of rheumatoid arthritis when combined with tofacitinib. Pharmacol Rep. 2020; 73(1):185-201. DOI: 10.1007/s43440-020-00188-x. View

13.

Li J, Zhang L, Zheng Y, Shao R, Liang Q, Yu W . BAD inactivation exacerbates rheumatoid arthritis pathology by promoting survival of sublining macrophages. Elife. 2020; 9. PMC: 7714394. DOI: 10.7554/eLife.56309. View

14.

Gao Y, Zheng X, Chang B, Lin Y, Huang X, Wang W . Intercellular transfer of activated STING triggered by RAB22A-mediated non-canonical autophagy promotes antitumor immunity. Cell Res. 2022; 32(12):1086-1104. PMC: 9715632. DOI: 10.1038/s41422-022-00731-w. View

15.

Zheng Y, Kang H, Wang B, Zhu Y, Mamun M, Zhao L . Curriculum vitae of HDAC6 in solid tumors. Int J Biol Macromol. 2023; 230:123219. DOI: 10.1016/j.ijbiomac.2023.123219. View

16.

Davis J, Ferreira D, Paige E, Gedye C, Boyle M . Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies. Clin Microbiol Rev. 2020; 33(3). PMC: 7289788. DOI: 10.1128/CMR.00035-19. View

17.

Barter M, Butcher A, Wang H, Tsompani D, Galler M, Rumsby E . HDAC6 regulates NF-κB signalling to control chondrocyte IL-1-induced MMP and inflammatory gene expression. Sci Rep. 2022; 12(1):6640. PMC: 9033835. DOI: 10.1038/s41598-022-10518-z. View

18.

Shen Z, Ji K, Cai Z, Huang C, He X, Xu H . Inhibition of HDAC6 by Tubastatin A reduces chondrocyte oxidative stress in chondrocytes and ameliorates mouse osteoarthritis by activating autophagy. Aging (Albany NY). 2021; 13(7):9820-9837. PMC: 8064156. DOI: 10.18632/aging.202736. View

19.

Zhang Y, Tawiah G, Zhang Y, Wang X, Wei X, Chen W . HDAC6 inhibition regulates substrate stiffness-mediated inflammation signaling in chondrocytes. Acta Biochim Biophys Sin (Shanghai). 2023; 55(12):1987-1998. PMC: 10753363. DOI: 10.3724/abbs.2023144. View

20.

Firestein G, McInnes I . Immunopathogenesis of Rheumatoid Arthritis. Immunity. 2017; 46(2):183-196. PMC: 5385708. DOI: 10.1016/j.immuni.2017.02.006. View